{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:23:02Z","timestamp":1785414182751,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate whether tranexamic acid (TXA) administration reduces the prevalence of severe postpartum hemorrhage (sPPH), defined as a hemoglobin drop of \u2265\u20093\u00a0g\/dL, in primiparous women undergoing vacuum-assisted vaginal delivery (VAVD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted at a large tertiary medical center, including all primiparous women undergoing VAVD between January 2021 and December 2022. TXA (1\u00a0g IV within 30\u00a0min of delivery) was administered at the discretion of the attending clinician, such that some women received TXA while others did not. The primary outcome was sPPH. Secondary outcomes included postpartum transfusion of blood products, absolute decline in hemoglobin levels, and additional clinical interventions related to hemorrhage, such as manual removal of the placenta or administration of uterotonic agents for the treatment of uterine atony. Initial comparisons were performed between TXA-treated and untreated women in the overall cohort. To account for baseline differences in the likelihood of receiving TXA, propensity score matching was performed using relevant clinical predictors; neonatal birthweight, prolonged second or third stage of labor, manual uterine revision. Logistic regression models were used for adjusted analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the study period, 6,580 primiparous women delivered, of whom 1,048 (15.9%) met the inclusion criteria and comprised the study cohort (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091,048). Of these, 383 (36.5%) received TXA, and 274 (26.1%) experienced sPPH. TXA-treated women had higher sPPH rates compared to untreated women (33.5% vs. 22.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), greater mean hemoglobin drop (2.54\u2009\u00b1\u20091.3 vs. 2.18\u2009\u00b1\u20091.3\u00a0g\/dL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and increased postpartum blood transfusion rates (3.7% vs. 1.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031). Propensity score matching (367 pairs) yielded similar results, with sPPH remaining more prevalent in the TXA group (31.7% vs. 18.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Primiparous women undergoing VAVD are at increased risk for sPPH. Administration of 1 gram of TXA within 30\u00a0min of delivery was not associated with a reduction in the prevalence of sPPH or the need for postpartum blood transfusion. Given the non-randomized design and retrospective nature of the study, it was not possible to determine whether TXA was administered prophylactically or in response to active bleeding. Nevertheless, TXA did not appear to reduce the prevalence of sPPH. Further research is needed to identify effective interventions for sPPH prevention in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-025-08438-7","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:45:04Z","timestamp":1767026704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tranexamic acid in the management of postpartum hemorrhage following vacuum-assisted vaginal delivery in primiparous women: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Orna","family":"Reichman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Margaliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan Bas","family":"Lando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Helman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Grisaru-Granovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"8438_CR1","unstructured":"Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA\/Population Division. Geneva: World Health Organization. 2023 https:\/\/iris.who.int\/handle\/10665\/366225."},{"issue":"6","key":"8438_CR2","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tun\u00e7alp \u00d6, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-33.","journal-title":"Lancet Glob Health"},{"key":"8438_CR3","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.04048","volume":"11","author":"R Musarandega","year":"2021","unstructured":"Musarandega R, Nyakura M, Machekano R, Pattinson R, Munjanja SP. Causes of maternal mortality in sub-Saharan Africa: a systematic review of studies published from 2015 to 2020. J Glob Health. 2021;11:04048.","journal-title":"J Glob Health"},{"key":"8438_CR4","volume-title":"Obstetrics: normal and problem pregnancies","author":"G Steven","year":"2019","unstructured":"Steven G, Niebyl JR, Galan HL, Eric R, Jauniaux M, Landon MB, Simpson JL, Driscoll DA. Obstetrics: normal and problem pregnancies. 8th ed. Philadelphia, PA: Elsevier; 2019.","edition":"8"},{"issue":"12","key":"8438_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/bjs\/znac252","volume":"109","author":"MPW Grocott","year":"2022","unstructured":"UK Royal Colleges Tranexamic Acid in Surgery Implementation Group, Grocott MPW, Murphy M, Roberts I, Sayers R, Toh CH. Tranexamic acid for safer surgery: the time is now. Br J Surg. 2022;109(12):1182\u20133.","journal-title":"Br J Surg"},{"key":"8438_CR6","first-page":"6","volume":"2015","author":"N Novikova","year":"2015","unstructured":"Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2015;2015:6.","journal-title":"Cochrane Database Syst Rev"},{"key":"8438_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"The CRASH2 collaborators","year":"2010","unstructured":"The CRASH2 collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH2): a randomised, placebo-controlled trial. Lancet. 2010;376:23\u201332.","journal-title":"Lancet"},{"issue":"10210","key":"8438_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","volume":"394","author":"CRASH-3 trial collaborators","year":"2019","unstructured":"CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713\u201323.","journal-title":"Lancet"},{"issue":"8","key":"8438_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1800942","volume":"379","author":"L Sentilhes","year":"2018","unstructured":"Sentilhes L, Winer N, Azria E, S\u00e9nat MV, Le Ray C, Vardon D, et al. Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med. 2018;379(8):731\u201342.","journal-title":"N Engl J Med"},{"issue":"1","key":"8438_CR10","volume":"1","author":"C Rohwer","year":"2025","unstructured":"Rohwer C, Rohwer AC, Cluver C, Ker K, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage after vaginal birth. Cochrane Database Syst Rev. 2025;1(1):CD007872.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10463","key":"8438_CR11","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(24)02102-0","volume":"404","author":"K Ker","year":"2024","unstructured":"Ker K, Sentilhes L, Shakur-Still H, Madar H, Deneux-Tharaux C, Saade G, et al. Tranexamic acid for postpartum bleeding: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet. 2024;404(10463):1657\u201367.","journal-title":"Lancet"},{"issue":"5","key":"8438_CR12","first-page":"407","volume":"30","author":"K Gungorduk","year":"2013","unstructured":"Gungorduk K, As\u0131c\u0131o\u011flu O, Y\u0131ld\u0131r\u0131m G, Ark C, Tekirda\u011f A\u0130, Bes\u0131moglu B. Can intravenous injection of Tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. Am J Perinatol. 2013;30(5):407\u201313.","journal-title":"Am J Perinatol"},{"issue":"60","key":"8438_CR13","first-page":"1","volume":"16","author":"M Mirghafourvand","year":"2013","unstructured":"Mirghafourvand M, Alizadeh SM, Abasalizadeh F, Shirdel M. The effect of intravenous tranexamic acid on hemoglobin and hematocrit levels after vaginal delivery: a randomized controlled trial. Iran J Obstet Gynecol Infertil. 2013;16(60):1\u20138.","journal-title":"Iran J Obstet Gynecol Infertil"},{"issue":"10","key":"8438_CR14","first-page":"590","volume":"36","author":"H Yang","year":"2001","unstructured":"Yang H, Zheng S, Shi C. [Clinical study on the efficacy of Tranexamic acid in reducing postpartum blood lose: a randomized comparative, multicenter trial] [Chinese]. Chung-Hua Fu Chan Ko Tsa Chih [Chinese. J Obstet Gynaecology]. 2001;36(10):590\u20132.","journal-title":"J Obstet Gynaecology]"},{"issue":"19","key":"8438_CR15","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1080\/14767058.2019.1571576","volume":"33","author":"G Saccone","year":"2020","unstructured":"Saccone G, Della Corte L, D\u2019Alessandro P, Ardino B, Carbone L, Raffone A, et al. Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage. J Matern Fetal Neonatal Med. 2020;33(19):3368\u201376.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10463","key":"8438_CR16","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0140-6736(24)01749-5","volume":"404","author":"WOMAN-Trial Collaborators","year":"2024","unstructured":"WOMAN-Trial Collaborators. The effect of Tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2024;404(10463):1645\u201356.","journal-title":"Lancet"},{"issue":"1","key":"8438_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2389302","volume":"56","author":"P Zhang","year":"2024","unstructured":"Zhang P, Jia YJ, Lv Y, Fan YF, Geng H, Zhao Y, et al. Effects of tranexamic acid preconditioning on the prevalence of postpartum haemorrhage in vaginal deliveries with identified risk factors in China: a prospective, randomized, open-label, blinded endpoint trial. Ann Med. 2024;56(1):2389302.","journal-title":"Ann Med"},{"issue":"12","key":"8438_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1055\/s-0036-1584579","volume":"33","author":"O Reichman","year":"2016","unstructured":"Reichman O, Gal M, Sela HY, Khayyat I, Emanuel M, Samueloff A. Grouping parturients by parity, previous-cesarean, and mode of delivery (P-C-MoD classification) better identifies groups at risk for postpartum hemorrhage. Am J Perinatol. 2016;33(12):1133\u20137.","journal-title":"Am J Perinatol"},{"key":"8438_CR19","unstructured":"Smith CM, Borders AE, King TL. Quantitative blood loss in obstetric hemorrhage. Committee opinion, number 794, American College of Obstetricians and Gynecologists. 2019. https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2019\/12\/quantitative-blood-loss-in-obstetric-hemorrhage"},{"issue":"8","key":"8438_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221216","volume":"14","author":"H Anger","year":"2019","unstructured":"Anger H, Durocher J, Dabash R, Winikoff B. How well do postpartum blood loss and common definitions of postpartum hemorrhage correlate with postpartum anemia and fall in hemoglobin? PLoS ONE. 2019;14(8):e0221216.","journal-title":"PLoS ONE"},{"issue":"12","key":"8438_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E Von Elm","year":"2014","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139.","journal-title":"Int J Surg"},{"issue":"1","key":"8438_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00404-016-4208-5","volume":"295","author":"L Hiersch","year":"2017","unstructured":"Hiersch L, Bergel-Bson R, Asher D, Aviram A, Gabby-Benziv R, Yogev Y, et al. Risk factors for post-partum hemorrhage following vacuum assisted vaginal delivery. Arch Gynecol Obstet. 2017;295(1):75\u201380.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"8438_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/GRF.0b013e3181cc406d","volume":"53","author":"Y Oyelese","year":"2010","unstructured":"Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol. 2010;53(1):147\u201356.","journal-title":"Clin Obstet Gynecol"},{"issue":"3\u20134","key":"8438_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bpa.2022.11.001","volume":"36","author":"J Bl\u00e1ha","year":"2022","unstructured":"Bl\u00e1ha J, Barto\u0161ov\u00e1 T. Epidemiology and definition of PPH worldwide. Best Pract Res Clin Anaesthesiol. 2022;36(3\u20134):325\u201339.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"10084","key":"8438_CR25","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","unstructured":"WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105\u201316.","journal-title":"Lancet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08438-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08438-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08438-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:45:06Z","timestamp":1767026706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-025-08438-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8438"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08438-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Shaare Zedek Medical Center (IRB #0329\u2009\u2212\u200924). Given the retrospective nature of the study and use of de-identified data, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1329"}}